| Institutions |
Authors |
Share |
|
AstraZeneca UK Limited, United Kingdom (UK)
|
5.000000
|
0.24 |
|
AstraZeneca United States, United States of America (USA)
|
3.000000
|
0.14 |
|
Avillion LLP, United Kingdom (UK)
|
3.000000
|
0.14 |
|
Rutgers, The State University of New Jersey (RU), United States of America (USA)
|
1.000000
|
0.05 |
|
Capital Allergy and Respiratory Disease Center (CARDC), United States of America (USA)
|
1.000000
|
0.05 |
|
North Carolina Clinical Research (NCCR), United States of America (USA)
|
1.000000
|
0.05 |
|
Avillion US Inc., United States of America (USA)
|
1.000000
|
0.05 |
|
Medical Research Institute of New Zealand (MRINZ), New Zealand
|
1.000000
|
0.05 |
|
Brigham and Women's Hospital (BWH), United States of America (USA)
|
1.000000
|
0.05 |
|
Monroe Carell Jr. Children's Hospital, VU, United States of America (USA)
|
1.000000
|
0.05 |
|
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)
|
1.000000
|
0.05 |
|
Phastar Ltd., United Kingdom (UK)
|
1.000000
|
0.05 |
|
University of Ferrara (UNIFE), Italy
|
1.000000
|
0.05 |
